NOAEL Studies
Humectant
L-Glutamic Acid NOAEL Studies
INCI: GLUTAMIC ACID
CAS: 56-86-0
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | NOAEL | 5000 | mg/kg bw/day | mouse | oral | NA | Developmental | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS DB | NOAEL | 10000 | mg/kg bw/day | rat | oral | 8 day | Short Term Toxicity | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
EFSA 5 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| EFSA | NOAEL | =3200 | mg/kg bw/day | Rat | oral: feed | - | other | EFSA ANS - 2017 - OutputID 2972 - behaviour - neurotoxicity - Re-evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives - doi:10.2903/j.efsa.2017.4910 |
| EFSA | NOAEL | =3200 | mg/kg bw/day | Rat | oral: feed | - | other | EFSA ANS - 2017 - OutputID 2972 - behaviour - neurotoxicity - Re-evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives - doi:10.2903/j.efsa.2017.4910 |
| EFSA | ADI (group) | =30 | mg/kg bw/day | Consumers | - | - | ADI (group) | EFSA ANS - 2017 - OutputID 2972 - Consumers - Re-evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives - doi:10.2903/j.efsa.2017.4910 |
| EFSA | ADI (group) | =30 | mg/kg bw/day | Consumers | - | - | ADI (group) | EFSA ANS - 2017 - OutputID 2972 - Consumers - Re-evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives - doi:10.2903/j.efsa.2017.4910 |
| EFSA | NOAEL | =3200 | mg/kg bw/day | Rat | oral | - | repeat dose other | LONG_REF=EFSA ANS (2017). Re-evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives. doi:10.2903/j.efsa.2017.4910.; TITLE=Re-evaluation of glutamic acid (E 620), sodium glutamate (E 621), potassium glutamate (E 622), calcium glutamate (E 623), ammonium glutamate (E 624) and magnesium glutamate (E 625) as food additives; AUTHOR=EFSA ANS; DOI=doi:10.2903/j.efsa.2017.4910; STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/65201d30e4b0f0a60ddd1165; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://zenodo.org/record/5076033#.Y9fEoXbMI2z; YEAR=2017; ORIGINAL_YEAR=2017; TOXICOLOGICAL_EFFECT=behavior; STUDY_GROUP=EFSA:15622588:M/F:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_847a1243a567da4cefd0e84f627f3c2a |
ToxValDB GESTIS DNEL 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| ToxValDB GESTIS DNEL | DNEL systemic | =10 | mg/m3 | Human | inhalation | - | Toxicity Value | STORED_SOURCE_RECORD=https://clowder.edap-cluster.com/files/6543dd69e4b045b9ff7cd87e; RECORD_SOURCE_LEVEL=Extraction document; SOURCE_URL=https://www.dguv.de/ifa/gestis/gestis-dnel-liste/index-2.jsp; STUDY_GROUP=GESTIS DNEL:15632396:-:--; QC_CATEGORY=Programmatically extracted from structured data source; Source overall passed QC, but this record was not manually checked; QC_STATUS=not determined; SOURCE_HASH=ToxValhc_b8b6c0572560ca3d846390bf7acd080e |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 3KX376GY7L | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C5H9NO4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"3KX376GY7L"} |
| openFDA substances | FDA UNII substance identifier | 3KX376GY7L | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C5H9NO4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"3KX376GY7L"} |
| openFDA substances | FDA UNII substance identifier | 3KX376GY7L | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C5H9NO4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"3KX376GY7L"} |
| openFDA substances | FDA UNII substance identifier | 3KX376GY7L | UNII | - | - | - | chemical | {"approval_status":null,"molecular_formula":"C5H9NO4","source_table":"substance_identifiers_fda","substance_class":"chemical","unii_code":"3KX376GY7L"} |